**Core Concept**
Disseminated intravascular coagulation (DIC) is a complex condition characterized by both widespread clotting and bleeding in the vascular system due to the consumption of clotting factors and platelets. This can occur in various clinical settings, including malignancies.

**Why the Correct Answer is Right**
In the context of acute myeloblastic leukemia (AML), DIC can develop due to the release of pro-coagulant substances from the tumor cells. The presence of a low fibrinogen level, prolonged prothrombin time (PT), and partial thromboplastin time (PTT) in this patient suggests DIC. The peripheral smear findings of AML also support this diagnosis. The consumption of clotting factors and platelets leads to a hypercoagulable state, which is then followed by a paradoxical bleeding tendency due to the exhaustion of these factors.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the clinical presentation described. The patient's condition is more consistent with DIC rather than a specific type of leukemia-related bleeding disorder.

**Option B:** While thrombotic thrombocytopenic purpura (TTP) can present with thrombocytopenia and bleeding, it is not typically associated with the laboratory findings seen in this patient, such as a prolonged PT and low fibrinogen level.

**Option C:** Hemophagocytic lymphohistiocytosis (HLH) is a condition characterized by an excessive immune response that can lead to cytopenias and organ dysfunction. However, it is not directly related to the laboratory findings and clinical presentation described in this case.

**Option D:** This option is not relevant to the clinical presentation described and does not address the underlying pathophysiology of DIC in the context of AML.

**Clinical Pearl / High-Yield Fact**
DIC can be a challenging condition to diagnose, as the laboratory findings may be non-specific. A low fibrinogen level and prolonged PT/PTT in the setting of a hematologic malignancy should raise suspicion for DIC.

**Correct Answer:** C.